AKCA Forecast and Technical Stock Analysis
Sell candidate since 2020-01-15 Loss -6.78% PDF
Akcea Therapeutics, Inc. fell by -4.11% in the last day ( Friday, 17th Jan 2020 ) from $17.78 to $17.05 and has now fallen 4 days in a row. During the day the stock fluctuated 4.59% from a day low at $17.00 to a day high of $17.78. The price has been going up and down for this period, and there has been a 1.37% gain for the last 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -44 064 shares and in total 218 774 shares bought and sold for approximately $3.73 million.
- 30 day high of the AKCA stock price was $19.87 and low was $16.15.
- 90 day high was $21.71 and low was $16.15.
- 52 week high for Akcea Therapeutics, Inc. - $35.82 and low - $13.90.
Akcea Therapeutics, Inc. lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. A break down the bottom trend line at $16.56 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -4.52% during the next 3 months and, with 90% probability hold a price between $15.81 and $19.35 at the end of this period.
There are few to none technical positive signals at the moment. Akcea Therapeutics, Inc. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $18.09 and $18.25. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday January 14, 2020, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 43 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Akcea Therapeutics, Inc. finds support from accumulated volume at $16.99.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.78 between high and low, or 4.59%. For the last week, the stock has had a daily average volatility of 5.92%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
5.92 %Average volatility
Very Low Low Medium High Very High
|AKCA $17.05 ($-0.73 -4.11%)|
AKCA is down $0.73 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for AKCA based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AKCA analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.